CORRECTED: N.J. Justices Back New Mesh Trial For C.R. Bard
The New Jersey Supreme Court on Tuesday backed the Appellate Division's decision to toss two pelvic mesh trial verdicts totaling $83 million against C.R. Bard Inc. and Johnson & Johnson's medical...To view the full article, register now.
Already a subscriber? Click here to view full article